NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/13/2026 10:39
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5,756.41 mln
Float19.24 mln
Earnings Date11/05/2026
EPS
9.71
Strong
P / E
29.75
Elevated
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-3.59
Highly reliable
1-Year Forecast
344
Attractive
Relative Strength
17
/ 100
Significantly lagging
Business Description
Ligand Pharmaceuticals is a Florida-based biopharmaceutical company founded in 1987 that builds revenue by licensing a broad portfolio of drug assets to partners around the world rather than selling medicines directly to patients. Its portfolio spans a wide range of medical needs, including cancer, infectious disease, bone health, diabetes, and rare conditions, with partner products already approved and generating royalties alongside a pipeline of drugs still in development. This business model allows Ligand to earn income from multiple revenue streams while sharing the costs and risks of bringing new treatments to market.